Literature DB >> 6301942

Segment-specific mutagenesis of the regulatory region in the Escherichia coli galactose operon: isolation of mutations reducing the initiation of transcription and translation.

S Busby, M Dreyfus.   

Abstract

Using hydroxylamine mutagenesis in vitro, mutations were introduced into a short DNA fragment containing the two overlapping promoters of the Escherichia coli galactose operon and the start of the first gal gene, galE. The mutagenised fragment was inserted into a lac expression plasmid. In such a vector, lac expression is controlled by the gal promoter region. Amongst eighteen candidates in which expression was reduced due to mutations in the gal fragment, twelve contained promoter mutations and six carried mutations that reduce the initiation of galE translation. The candidates in which promoter activity was reduced contained mutations affecting the promoter P1, which is dependent on the cyclic AMP-receptor protein complex (cAMP-CRP) for activation. All carried mutations in the sequence 5'GTGA3' at the CRP binding site. One of the twelve also contained a second mutation affecting the second promoter, P2, which normally functions in the absence of cAMP-CRP. Amongst the six candidates affecting galE translation, two contained a mutation that changes the initiator codon from AUG to AUA and almost completely suppresses galE expression. The mutations in the other four candidates affect the ribosome binding sequence, 5'GGAG3'. However, multiple mutations that abolish this sequence do not totally suppress galE expression, showing that there must be another way to guide ribosomes to the correct initiation site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301942     DOI: 10.1016/0378-1119(83)90154-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  27 in total

1.  Sequence elements in the Escherichia coli araFGH promoter.

Authors:  W Hendrickson; C Flaherty; L Molz
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

2.  Overexpression, purification and characterization of the Escherichia coli MelR transcription activator protein.

Authors:  R Caswell; J Williams; A Lyddiatt; S Busby
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

3.  6S RNA function enhances long-term cell survival.

Authors:  Amy E Trotochaud; Karen M Wassarman
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

4.  Identification of a strong promoter of bacteriophage MB78 that lacks consensus sequence around minus 35 region and interacts with phage specific factor.

Authors:  M A Zargar; B Pandey; R Sharma; M Chakravorty
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Transcriptional and translational signals of the uidA gene in Escherichia coli K12.

Authors:  C Blanco
Journal:  Mol Gen Genet       Date:  1987-07

6.  Overlapping promoters and their control in Escherichia coli: the gal case.

Authors:  M Herbert; A Kolb; H Buc
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

7.  An initiator codon mutation in ornithine-delta-aminotransferase causing gyrate atrophy of the choroid and retina.

Authors:  G A Mitchell; L C Brody; J Looney; G Steel; M Suchanek; C Dowling; V Der Kaloustian; M Kaiser-Kupfer; D Valle
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

8.  Translational polarity of a mutation in the initiator AUG codon of the lambda cI gene.

Authors:  G N Gussin; S Brown; K Matz
Journal:  Genetics       Date:  1987-10       Impact factor: 4.562

9.  Secondary structure as primary determinant of the efficiency of ribosomal binding sites in Escherichia coli.

Authors:  A C Looman; J Bodlaender; M de Gruyter; A Vogelaar; P H van Knippenberg
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

10.  Spot 42 RNA mediates discoordinate expression of the E. coli galactose operon.

Authors:  Thorleif Møller; Thomas Franch; Christina Udesen; Kenn Gerdes; Poul Valentin-Hansen
Journal:  Genes Dev       Date:  2002-07-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.